PlainRecalls
FDA Drug Low Class III Terminated

Lacosamide Oral Solution, USP, CV, 10mg/mL, packaged in 200 mL bottle, Rx Only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, Manufactured By: HETERO LABS LIMITED, Jeedimetla, Hyderabad - 500 055, India, NDC 31722-627-26

Reported: December 21, 2022 Initiated: December 6, 2022 #D-0094-2023

Product Description

Lacosamide Oral Solution, USP, CV, 10mg/mL, packaged in 200 mL bottle, Rx Only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, Manufactured By: HETERO LABS LIMITED, Jeedimetla, Hyderabad - 500 055, India, NDC 31722-627-26

Reason for Recall

Failed Excipient Specifications: out of specification result observed for p-Hydroxybenzoic Acid content

Details

Units Affected
N/A
Distribution
USA Nationwide
Location
Piscataway, NJ

Frequently Asked Questions

What product was recalled?
Lacosamide Oral Solution, USP, CV, 10mg/mL, packaged in 200 mL bottle, Rx Only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, Manufactured By: HETERO LABS LIMITED, Jeedimetla, Hyderabad - 500 055, India, NDC 31722-627-26. Recalled by Camber Pharmaceuticals, Inc. Units affected: N/A.
Why was this product recalled?
Failed Excipient Specifications: out of specification result observed for p-Hydroxybenzoic Acid content
Which agency issued this recall?
This recall was issued by the FDA Drug on December 21, 2022. Severity: Low. Recall number: D-0094-2023.